These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 7593727)
1. Moclobemide for depression: an Australian psychiatric practice study. Tiller JW; Johnson GF; Burrows GD J Clin Psychopharmacol; 1995 Aug; 15(4 Suppl 2):31S-34S. PubMed ID: 7593727 [TBL] [Abstract][Full Text] [Related]
2. Moclobemide versus fluoxetine for major depressive episodes. Geerts S; Bruynooghe F; De Cuyper H; Demeulemeester F; Haazen L Clin Neuropharmacol; 1994; 17 Suppl 1():S50-7. PubMed ID: 7954484 [TBL] [Abstract][Full Text] [Related]
3. [Customary antidepressive treatment in Hungary: moclobemid therapy in everyday practice]. Bartkó G Orv Hetil; 1997 Sep; 138(37):2341-5. PubMed ID: 9340582 [TBL] [Abstract][Full Text] [Related]
4. A double-blind comparison of moclobemide and thioridazine versus moclobemide and placebo in the treatment of refractory, severe depression. Stabl M; Kasas A; Blajev B; Bajetta G; Zöchling R; Holsboer-Trachsler E; Realini R; Schäublin-Loidl M J Clin Psychopharmacol; 1995 Aug; 15(4 Suppl 2):41S-45S. PubMed ID: 7593730 [TBL] [Abstract][Full Text] [Related]
5. A comparison of the efficacy and tolerability of moclobemide given as a single daily dose or in three divided doses per day for the treatment of patients with a major depressive episode (DSM-III-R). Newburn G; Edwards R; Thomas H; Collier J; Fox K; Collins C; Cramer D; Reeves J; Caracatsanis A J Clin Psychopharmacol; 1995 Aug; 15(4 Suppl 2):10S-15S. PubMed ID: 7593724 [TBL] [Abstract][Full Text] [Related]
6. Moclobemide and placebo in mild major depression: a double-blind randomized trial. Ose E; Holm P Psychopharmacology (Berl); 1992; 106 Suppl():S114-5. PubMed ID: 1546122 [TBL] [Abstract][Full Text] [Related]
7. Double-blind comparison of moclobemide, imipramine and placebo in depressive patients. Ucha Udabe R; Márquez CA; Traballi CA; Portes N Acta Psychiatr Scand Suppl; 1990; 360():54-6. PubMed ID: 2123367 [TBL] [Abstract][Full Text] [Related]
8. Moclobemide versus fluoxetine for a major depressive episode. Reynaert C; Parent M; Mirel J; Janne P; Haazen L Psychopharmacology (Berl); 1995 Mar; 118(2):183-7. PubMed ID: 7617806 [TBL] [Abstract][Full Text] [Related]
9. Moclobemide versus fluoxetine for double depression: a randomized double-blind study. Duarte A; Mikkelsen H; Delini-Stula A J Psychiatr Res; 1996; 30(6):453-8. PubMed ID: 9023788 [TBL] [Abstract][Full Text] [Related]
10. Moclobemide versus fluoxetine in the treatment of inpatients with major depression. Gattaz WF; Vogel P; Kick H; Kohnen R J Clin Psychopharmacol; 1995 Aug; 15(4 Suppl 2):35S-40S. PubMed ID: 7593728 [TBL] [Abstract][Full Text] [Related]
11. Moclobemide versus clomipramine in the treatment of depression: a double-blind multicentre study in Belgium. Dierick M; Cattiez P; Franck G; Burton P; Defleur J; Hermans W; Roelandts A; Wolfrum C; Berger M; Hellstern K Acta Psychiatr Scand Suppl; 1990; 360():50-1. PubMed ID: 2248071 [TBL] [Abstract][Full Text] [Related]
12. Moclobemide and sertraline in the treatment of depressive disorders: a comparative study. Orsel Donbak S; Turkçapar MH; Ozturk Kiliç EZ; Demirergi N; Akdemir A; Sirin A; Ozbay MH Acta Psychiatr Belg; 1995; 95(3):139-51. PubMed ID: 8525856 [TBL] [Abstract][Full Text] [Related]
13. Multicenter double-blind study of moclobemide and maprotiline. Vaz-Serra A; Figueira ML; Firmino H; Albuquerque AJ; Jara JM; Pestana LC Clin Neuropharmacol; 1994; 17 Suppl 1():S38-49. PubMed ID: 7954483 [TBL] [Abstract][Full Text] [Related]
14. Moclobemide versus fluoxetine in the treatment of major depressive disorder in adults. Lapierre YD; Joffe R; McKenna K; Bland R; Kennedy S; Ingram P; Reesal R; Rickhi BG; Beauclair L; Chouinard G; Annable L J Psychiatry Neurosci; 1997 Mar; 22(2):118-26. PubMed ID: 9074306 [TBL] [Abstract][Full Text] [Related]
15. Moclobemide twice daily in the treatment of major depressive episode: a double-blind, multicenter comparison with different three-times-daily dosage schedules. Gagiano CA; Hart GA; Bodemer W; Schall R Clin Neuropharmacol; 1994; 17 Suppl 1():S1-8. PubMed ID: 7954480 [TBL] [Abstract][Full Text] [Related]
16. Moclobemide twice daily in the treatment of major depressive episode: a double-blind, multicenter comparison with different three times daily dosage schedules. Gagiano CA; Müller FG; Berk M; Joubert PM; Brown RG; Schall R J Clin Psychopharmacol; 1995 Aug; 15(4 Suppl 2):4S-9S. PubMed ID: 7593729 [TBL] [Abstract][Full Text] [Related]
17. Moclobemide in continuation treatment of major depressive episodes: an open follow-up study over six months. Gagiano CA; Müller FG; de Kock RF; Schall R J Clin Psychopharmacol; 1995 Aug; 15(4 Suppl 2):46S-50S. PubMed ID: 7593731 [TBL] [Abstract][Full Text] [Related]
18. Moclobemide, imipramine and placebo in the treatment of major depression. Versiani M; Nardi AE; Mundim FD; Alves A; Schmid-Burgk W Acta Psychiatr Scand Suppl; 1990; 360():57-8. PubMed ID: 2248073 [TBL] [Abstract][Full Text] [Related]
19. Comparison of the efficacy and tolerability of moclobemide and maprotiline in depressed patients treated by general practitioners. Gachoud JP; Dick P; Köhler M Clin Neuropharmacol; 1994; 17 Suppl 1():S29-37. PubMed ID: 7954482 [TBL] [Abstract][Full Text] [Related]
20. Antidepressant efficacy and quality of life in depression: a double-blind study with moclobemide and fluoxetine. Lonnqvist J; Sintonen H; Syvälahti E; Appelberg B; Koskinen T; Mannikko T; Mehtonen OP; Naarala M; Sihvo S; Auvinen J Acta Psychiatr Scand; 1994 Jun; 89(6):363-9. PubMed ID: 8085464 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]